- Home
- SXTC vs NEPH Comparison
SXTC vs NEPH Comparison
Compare SXTC & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- NEPH
- Stock Information
- Founded
- SXTC 2005
- NEPH 1997
- Country
- SXTC China
- NEPH United States
- Employees
- SXTC N/A
- NEPH N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- NEPH Medical/Dental Instruments
- Sector
- SXTC Health Care
- NEPH Health Care
- Exchange
- SXTC Nasdaq
- NEPH Nasdaq
- Market Cap
- SXTC 14.0M
- NEPH 16.8M
- IPO Year
- SXTC 2019
- NEPH 2004
- Fundamental
- Price
- SXTC $2.01
- NEPH $1.99
- Analyst Decision
- SXTC
- NEPH Buy
- Analyst Count
- SXTC 0
- NEPH 1
- Target Price
- SXTC N/A
- NEPH $5.00
- AVG Volume (30 Days)
- SXTC 12.0M
- NEPH 4.1K
- Earning Date
- SXTC 01-01-0001
- NEPH 05-08-2025
- Dividend Yield
- SXTC N/A
- NEPH N/A
- EPS Growth
- SXTC N/A
- NEPH N/A
- EPS
- SXTC 20.77
- NEPH 0.01
- Revenue
- SXTC $1,818,404.00
- NEPH $14,162,000.00
- Revenue This Year
- SXTC N/A
- NEPH $9.23
- Revenue Next Year
- SXTC N/A
- NEPH $12.99
- P/E Ratio
- SXTC $0.09
- NEPH $283.07
- Revenue Growth
- SXTC 6.78
- NEPH N/A
- 52 Week Low
- SXTC $0.30
- NEPH $1.36
- 52 Week High
- SXTC $5.70
- NEPH $2.55
- Technical
- Relative Strength Index (RSI)
- SXTC 48.57
- NEPH 56.14
- Support Level
- SXTC $0.95
- NEPH $1.78
- Resistance Level
- SXTC $2.45
- NEPH $2.10
- Average True Range (ATR)
- SXTC 0.69
- NEPH 0.13
- MACD
- SXTC 0.01
- NEPH -0.01
- Stochastic Oscillator
- SXTC 46.70
- NEPH 76.09
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.